BSE, NSE, Stock Market

Sensex Today | Stock Market LIVE on Wednesday, June 25, 2025: In the broader markets, the Nifty MidCap index and the Nifty SmallCap index added 0.38 per cent and 1.47 per cent

Stock Market LIVE: Sensex, Nifty power ahead; Smallcap stocks rally; IT, media lead gains; MCX up 6%

Business Standard

Acme Solar Holdings said that it's wholly owned subsidiary, ACME Sikar Solar has secured a 25-year power purchase agreement with the Solar Energy Corporation of India (SECI) for 300 MW capacity in Rajasthan at a fixed tariff of Rs 3.05 per kWh.

Acme Solar's subsidiary signs 25-year PPA with SECI for 300 MW at Rs 3.05/kWh

Capital Market Automatic

Ellenbarrie Industrial Gases IPO Day 2 subscription: The company raised ₹256 crore from anchor investors ahead of the IPO

Ellenbarrie Industrial IPO Day 2 update: Subscription lags at 20%, GMP 6%

SEPC successfully raises Rs 350 cr via rights issue

Dr Lal Pathlabs  (DLPL) has expanded its genomics capabilities by adding Illumina's NovaSeq X Series to its dedicated genomics division, Genevolve. With the integration of Illumina's latest technology, DLPL can now deliver faster and more accurate genomic research insights. 

Dr Lal Pathlabs strengthens its genomics capabilities with Illumina's NovaSeq X Series

Indian Rupee saw continued gains and broke under 86 per US dollar mark today. INR currently quotes up 11 paise at 85.93 per dollar amid firm equities. INR recovered from record low level and closed with a steep gain of around 75 paise at 86.05 against the US dollar as global crude oil prices tanked following hopes of deescalation in Middle East tensions. A weak greenback and positive sentiments in the domestic equity markets further boosted the local currency. Brent crude lost more than 3% to break under to $70 per barrel as US President Donald Trump announced that Iran and Israel agreed to a ceasefire.

Rupee adds to yesterday's gains

Lupin announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its abbreviated new drug application (ANDA) for Prucalopride tablets.

Lupin receives USFDA approval for generic Prucalopride tablets

Radico Khaitan Ltd is quoting at Rs 2718.7, up 1.32% on the day as on 12:49 IST on the NSE. The stock is up 51.04% in last one year as compared to a 5.55% slide in NIFTY and a 3.13% slide in the Nifty FMCG index.

Radico Khaitan Ltd gains for third straight session

Lupin has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Prucalopride Tablets, 1 mg, and 2 mg. 

Lupin receives USFDA approval for Prucalopride Tablets

Companies News: Get latest company news, company results, company interviews, company financials, company analysis, company disclosure, corporate news, company announcements at Business Standard.

Company News: Company Business News, Indian Companies News, Company Analysis, Corporate Industry News

Get latest company news, company results, company interviews, company financials, company analysis, company disclosure, corporate news, company announcements at Business Standard.

Modex International Securities Ltd News